Xopenex and Buspirone hcl drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Xopenex and Buspirone hcl. Common interactions include pruritus among females and arthritis among males.

The phase IV clinical study analyzes what interactions people who take Xopenex and Buspirone hcl have. It is created by eHealthMe based on reports of 72 people who take Xopenex and Buspirone hcl from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Jan, 30, 2023

72 people who take Xopenex and Buspirone hcl together, and have interactions are studied.

What is Xopenex?

Xopenex has active ingredients of levalbuterol hydrochloride. It is often used in asthma. eHealthMe is studying from 12,731 Xopenex users for its effectiveness, alternative drugs and more.

What is Buspirone hcl?

Buspirone hcl has active ingredients of buspirone hydrochloride. It is often used in stress and anxiety. eHealthMe is studying from 7,693 Buspirone hcl users for its effectiveness, alternative drugs and more.

Number of Xopenex and Buspirone hcl reports submitted per year:

Common Xopenex and Buspirone Hcl drug interactions by gender *:

female:

Pruritus
Blindness transient
Hyperacusis
Cough
Deafness transitory
Erythema
Loss of consciousness
Chronic kidney disease
Drug hypersensitivity
Migraine

male:

Arthritis
Back pain
Suicidal ideation
Suicide attempt
Obsessive-compulsive disorder
Coronary artery disease
Emotional distress
Gastrooesophageal reflux disease
Injury
Mental disorder

Common Xopenex and Buspirone Hcl drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

Pre-existing condition improved
Therapeutic response unexpected

20-29:

Rash
Infection

30-39:

Pain

40-49:

Blindness transient
Erythema
Hyperacusis
Loss of consciousness
Pruritus
Auricular swelling
Deafness transitory
Hypersensitivity
Local swelling
Deafness

50-59:

Constipation
Cough
Dyspnoea
Herpes zoster
Inguinal hernia
Malaise
Nausea
Oropharyngeal pain
Oxygen saturation decreased
Pain in extremity

60+:

Chronic kidney disease
Respiratory failure
Fluid retention
Malaise
Myocardial infarction
Pneumonia
Surgery
Therapeutic response unexpected
Type 2 diabetes mellitus
Supraventricular tachycardia

Common conditions people have *:

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 36 people, 50.00%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 20 people, 27.78%
Depression: 15 people, 20.83%
Wheezing (a high-pitched whistling sound made while you breath): 9 people, 12.50%
Migraine (headache): 9 people, 12.50%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 8 people, 11.11%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 8 people, 11.11%
Indigestion: 7 people, 9.72%
Seasonal Affective Disorder (a type of depression that occurs at a certain time of the year, usually in the winter): 7 people, 9.72%
Blood Testosterone Abnormal: 6 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Xopenex and Buspirone hcl?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.